Hyperprolactinemia, an often-undesirable side effect of many antipsychotics, is largely due to the blockade of dopamine D2 receptors, which interrupts the dopaminergic inhibition of the prolactin release. The gene discussed is DRD2; the disease is hyperprolactinemia.